Temsirolimus , 99% , 162635-04-3

Synonym(s):
42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-rapamycin;CCI-779

CAS NO.：162635-04-3

Empirical Formula: C56H87NO16

Molecular Weight: 1030.29

MDL number: MFCD00934421

EINECS: 686-177-0

PRODUCT Properties

• Melting point: 99-101°C
• Boiling point: 1048.4±75.0 °C(Predicted)
• Density: 1.21
• Flash point: 587.8℃
• storage temp.: room temp
• solubility: Soluble in chloroform, methanol.
• pka: 10.40±0.70(Predicted)
• form: powder
• color: white to off-white
• Merck: 14,9142
• InChIKey: CBPNZQVSJQDFBE-FUXHJELOSA-N

Description and Uses

While renal cell carcinoma (RCC) accounts for only 2 3% of all cancers, the 5-year survival rate for advanced RCC disease is only 5 10%, with approximately 13,000 deaths occurring annually (US statistics only). Immunotherapeutic cytokine options, such as IFN-αand IL-2, have traditionally been frontline treatments, but these agents are not efficacious in all patients and can cause serious side effects. In addition, bevacizumab, a monoclonal antibody against VEGF, has also demonstrated prolongation of PFS. The newest entry for this indication focuses on targets that are downstream from VEGF. Temsirolimus is an inhibitor of the serine/threonine kinase mTOR, which is the mammalian target of rapamycin. mTOR has been implicated in cell replication through control of the cell cycle translation of specific mRNAs. Inhibition of mTOR prevents phosphorylation of the 4E binding protein-1 and the 40S ribosomal protein S6 kinase that are responsible for cell cycle protein translation initiation; cell cycle arrest occurs as the result of termination of cell division from the G1 to the S phase. Disruption of mTOR signaling also has antiangiogenic effects that could be deemed essential in combating RCC, which is driven by unregulated angiogenesis. Temsirolimus is the 2,2-bis(hydroxymethyl)propionate ester of rapamycin (sirolimus), a macrolide fungicide isolated from the bacteria Streptomyces hygroscopicus. Similar to its parent sirolimus, temsirolimus interacts with mTOR through its complex with FK-506 binding protein 12.

Temsirolimus is a semisynthetic macrocyclic lactone prepared from rapamycin by selective acylation of the 42-hydroxy group with a protected bis(dihydromethyl)propionic acid, followed by deprotection. Like all tacrolimus analogues, temsirolimus binds to receptor protein, FKBP12. The complex then binds to mTOR preventing it from interacting with target proteins. Temsirolimus is extensively cited in the literature with over 700 citations.

Safety

• Symbol(GHS): GHS08
• Signal word: Danger
• Hazard statements: H360-H413
• Precautionary statements: P501-P273-P202-P201-P280-P308+P313-P405
• Safety Statements: 24/25
• WGK Germany: 3
• RTECS: VE6257000
• HS Code: 29349990
• Hazardous Substances Data: 162635-04-3(Hazardous Substances Data)